The impact of budesonide inhalation suspension for asthma hospitalization: In terms of length of stay, recovery time from symptoms, and hospitalization costs

Background: Hospitalization is a major cause of medical expenditure for asthma. Budesonide inhalation suspension (BIS) may assist in reducing asthma-related symptoms in severe asthma exacerbation. However, its effectiveness for hospitalized patients remains poorly known. The objective of this study...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Keima Ito, Yoshihiro Kanemitsu, Kensuke Fukumitsu, Yoshitsugu Inoue, Hirono Nishiyama, Sayaka Yamamoto, Yuki Kitamura, Ryota Kurokawa, Norihisa Takeda, Satoshi Fukuda, Takehiro Uemura, Tomoko Tajiri, Osamu Takakuwa, Hirotsugu Ohkubo, Masaya Takemura, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Akio Niimi
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2020-10-01
Schriftenreihe:	Allergology International
Schlagworte:	Budesonide inhalation suspension Hospitalization costs Length of hospital stay Respiratory infection Severe asthma exacerbation
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S1323893020300538
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!